DuPont de Nemours Inc
For the period ended Dec 31, 2023. Filed Feb 15, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 15, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
DuPont de Nemours, Inc.Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
DUPONT DE NEMOURS, INC.
Registrant
Date: February 15, 2024
| By: | /s/ MICHAEL G. GOSS |
|---|---|
| Name: | Michael G. Goss |
| Title: | Vice President and Controller |
| City: | Wilmington |
| State: | Delaware |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title(s) | Date |
| /s/ LORI KOCH | Executive Vice President andChief Financial Officer(Principal Financial Officer) | February 15, 2024 |
| Lori Koch | ||
| /s/ MICHAEL G. GOSS | Vice President and Controller | February 15, 2024 |
| Michael G. Goss | (Principal Accounting Officer) | |
We, the undersigned directors and officers of DuPont de Nemours, Inc, hereby severally constitute Erik T. Hoover, Senior Vice President & General Counsel and Peter W. Hennessey, Vice President, Associate General Counsel & Corporate Secretary, and each of them singly, as our true and lawful attorneys with full power to them and each of them to sign for us, in our names in the capacities indicated below, any and all amendments or supplements to this Annual Report on Form 10-K and to cause same to be filed with the U.S. Securities and Exchange Commission pursuant to the Securities and Exchange Act of 1934.
| Signature | Title(s) | Date |
| /s/ EDWARD D. BREEN | Chief Executive Officer and Director | February 15, 2024 |
| Edward D. Breen | (Principal Executive Officer) | |
| /s/ AMY G. BRADY | Director | February 15, 2024 |
| Amy G. Brady | ||
| /s/ RUBY R. CHANDY | Director | February 15, 2024 |
| Ruby R. Chandy | ||
| /s/ TERRENCE R. CURTIN | Director | February 15, 2024 |
| Terrence R. Curtin | ||
| /s/ ALEXANDER M. CUTLER | Director | February 15, 2024 |
| Alexander M. Cutler | ||
| /s/ ELEUTHERE I. DU PONT | Director | February 15, 2024 |
| Eleuthère I. du Pont | ||
| /s/ KRISTINA M. JOHNSON | Director | February 15, 2024 |
| Kristina M. Johnson | ||
| /s/ LUTHER C. KISSAM | Director | February 15, 2024 |
| Luther C. Kissam | ||
| /s/ FREDERICK M. LOWERY | Director | February 15, 2024 |
| Frederick M. Lowery | ||
| /s/ DEANNA M. MULLIGAN | Director | February 15, 2024 |
| Deanna M. Mulligan | ||
| /s/ STEVEN M. STERIN | Director | February 15, 2024 |
| Steven M. Sterin | ||
Index to the Consolidated Financial Statements
| Page(s) | |
| Consolidated Financial Statements: | |
|---|---|
| Management's Reports on Responsibility for Financial Statements and Internal Control over Financial Reporting | F-2 |
| Report of Independent Registered Public Accounting Firm (PCAOB ID 238) | F-3 |
| Consolidated Statements of Operations for the years ended December 31, 2023, 2022 and 2021 | F-6 |
| Consolidated Statements of Comprehensive Income for the years ended December 31, 2023, 2022 and 2021 | F-7 |
| Consolidated Balance Sheets as of December 31, 2023 and December 31, 2022 | F-8 |
| Consolidated Statements of Cash Flows for the years ended December 31, 2023, 2022 and 2021 | F-9 |
| Consolidated Statements of Equity for the years ended December 31, 2023, 2022 and 2021 | F-11 |
| Notes to the Consolidated Financial Statements | F-12 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.